Jon Lecanda
Impact in
-
- Cancer Cells and Metastasis
- Drug Transport and Resistance Mechanisms
- Cancer-related Molecular Pathways
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 10
- Cancer-related Molecular Pathways 4
- Cancer Cells and Metastasis 3
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- Jesús PrìetoJuan F. MedinaAlfonso CalvoDiego SerranoLeslie I. GoldJeffrey E. GreenRaúl CatenaVíctor Segura
- Journals
- Biochemical and Biophysical Research Communications (4 papers)Cell Cycle (2 papers)Experimental Cell Research (2 papers)PLoS ONE (2 papers)Cancer Research (2 papers)
- Partner nations
- SpainUnited StatesIran
In The Last Decade
Jon Lecanda
14 papers receiving 523 citations
Peers
Comparison fields: 5 of 82
- Oncology 226
- Cancer Research 81
- Molecular Biology 294
- Hepatology 33
- Immunology 84
Countries citing papers authored by Jon Lecanda
This map shows the geographic impact of Jon Lecanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Lecanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Lecanda more than expected).
Fields of papers citing papers by Jon Lecanda
This network shows the impact of papers produced by Jon Lecanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Lecanda. The network helps show where Jon Lecanda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jon Lecanda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 2 | |
| 2 | 2016 | 11 | |
| 3 | 2012 | 25 | |
| 4 | 2012 | 57 | |
| 5 | 2010 | 25 | |
| 6 | 2010 | 0 | |
| 7 | 2009 | 42 | |
| 8 | 2009 | 101 | |
| 9 | 2007 | 28 | |
| 10 | 2004 | 30 | |
| 11 | 2003 | 12 | |
| 12 | 2003 | 64 | |
| 13 | 2000 | 41 | |
| 14 | 2000 | 65 | |
| 15 | 2000 | 25 | |
| 16 | 2000 | 0 |
About Jon Lecanda
Jon Lecanda is a scholar working on Oncology, Cancer Research, Molecular Biology, Hepatology and Cell Biology, having authored 16 papers that have together received 528 indexed citations. Recurring topics across this work include TGF-β signaling in diseases (4 papers), Cancer-related Molecular Pathways (4 papers), Pancreatic function and diabetes (4 papers), Ion Transport and Channel Regulation (3 papers), Cancer Cells and Metastasis (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Ion channel regulation and function (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Oncology (226 citations), Cancer Research (81 citations), Molecular Biology (294 citations), Hepatology (33 citations) and Immunology (84 citations). Jon Lecanda has collaborated with scholars based in Spain, United States and Iran. Frequent co-authors include Jesús Prìeto, Juan F. Medina, Alfonso Calvo, Diego Serrano, Leslie I. Gold, Jeffrey E. Green, Raúl Catena, Víctor Segura, Raquel Urtasun and Cheng Qian. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cell Cycle, Experimental Cell Research, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.